Literature DB >> 29931491

Screening and Identification of the Metabolites of Water Extracts of Raw and Honey-Processed Astragalus in Rat Urine Based on UHPLC/ESI-Q-TOF-MS and Multivariate Statistical Analysis.

Jing Huang1, Hongyuan Chen2,3,4, Chanyi Li1, Wuping Liu1, Wenjie Ma1, Wen Rui5,6,7.   

Abstract

Radix Astragali is a famous traditional Chinese medicine and honey-processed Astragalus is a product of Radix Astragali acquired by honey-processing. These two products are widely utilized to treat various diseases. In this study, we screened bioactive components and metabolites of raw and honey-processed Astragalus in rat urine by ultra-performance liquid chromatography equipped with electrospray ionization/quadrupole time-of-flight mass spectrometry (UHPLC/ESI-Q-TOF-MS) combined with multivariate statistical analysis. In total, 62 compounds, including 7 parent compounds and 55 metabolites, were detected and 11 metabolites were characterized for the first time. The identified metabolites indicated that the metabolic reactions of Astragalus in rats included hydroxylation, glucuronidation, deglucosidation, monomethylation, demethylation, sulfation, hydrogenation, and dehydroxylation. The metabolic pathways of raw and honey-processed Astragalus in rat urine also were clarified. Through multivariate statistical analysis of the data of the raw and honey-processed Astragalus groups, we found that 20 compounds were differential components and that 1 metabolite only existed in the honey-processed Astragalus group. The differences in these ingredients between these two groups might provide the basis for interpreting the biologic activity differences in traditional Chinese medicine treatments. Graphical Abstract.

Entities:  

Keywords:  Honey-processed; Metabolite; Multivariate statistical analysis; Radix Astragali; UHPLC/ESI-Q-TOF-MS

Mesh:

Substances:

Year:  2018        PMID: 29931491     DOI: 10.1007/s13361-018-2003-1

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  21 in total

1.  Rapid screening and identification of the differences between metabolites of Cistanche deserticola and C. tubulosa water extract in rats by UPLC-Q-TOF-MS combined pattern recognition analysis.

Authors:  Yang Li; Ying Peng; Mengyue Wang; Guisheng Zhou; Yulong Zhang; Xiaobo Li
Journal:  J Pharm Biomed Anal       Date:  2016-09-14       Impact factor: 3.935

2.  Isolation, identification and antiviral activities of metabolites of calycosin-7-O-β-D-glucopyranoside.

Authors:  Luying Chen; Zhixiong Li; Yihong Tang; Xiaolan Cui; Ronghua Luo; Shanshan Guo; Yongtang Zheng; Chenggang Huang
Journal:  J Pharm Biomed Anal       Date:  2011-06-01       Impact factor: 3.935

3.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

Authors:  Joshua-Ka-Shun Ko; Flora-Ying-Lee Lam; Andrew-Pok-Lap Cheung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

4.  Profiling and identification of the metabolites of calycosin in rat hepatic 9000×g supernatant incubation system and the metabolites of calycosin-7-O-β-D-glucoside in rat urine by HPLC-DAD-ESI-IT-TOF-MS(n) technique.

Authors:  Ya-Zhou Zhang; Feng Xu; Jing Dong; Jing Liang; Yuki Hashi; Ming-Ying Shang; Dong-Hui Yang; Xuan Wang; Shao-Qing Cai
Journal:  J Pharm Biomed Anal       Date:  2012-06-12       Impact factor: 3.935

5.  Screening and identification of multiple constituents and their metabolites of Fangji Huangqi Tang in rats by ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry basing on coupling data processing techniques.

Authors:  Xiaoli Wang; Xiao Liu; Xiaoyan Xu; Tingting Zhu; Fa Shi; Kunming Qin; Baochang Cai
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-01-24       Impact factor: 3.205

6.  Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS.

Authors:  Jian Shi; Liang Zheng; Zhufen Lin; Chuqi Hou; Wenqin Liu; Tongmeng Yan; Lijun Zhu; Ying Wang; Linlin Lu; Zhongqiu Liu
Journal:  J Ethnopharmacol       Date:  2015-04-23       Impact factor: 4.360

7.  An analysis on the suppression of NO and PGE2 by diphenylheptane A and its effect on glycerophospholipids of lipopolysaccharide-induced RAW264.7 cells with UPLC/ESI-QTOF-MS.

Authors:  Yuqi She; Qifan Zheng; Xuerong Xiao; Xia Wu; Yifan Feng
Journal:  Anal Bioanal Chem       Date:  2016-03-30       Impact factor: 4.142

8.  Identification of metabolites of Danggui Buxue Tang in rat urine by liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry.

Authors:  Chang-Yin Li; Lian-Wen Qi; Ping Li; Xiao-Dong Wen; Yan-Fei Zhu; E-Hu Liu; Zhen Gong; Xiao-Lin Yang; Mei-Ting Ren; Yan-Jing Li; Xiao-Xiao Ge
Journal:  Rapid Commun Mass Spectrom       Date:  2009-07       Impact factor: 2.419

9.  In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus.

Authors:  William Chi Shing Cho; Kwok Nam Leung
Journal:  J Ethnopharmacol       Date:  2007-05-31       Impact factor: 4.360

10.  Cardioprotective effects of Astragali Radix against isoproterenol-induced myocardial injury in rats and its possible mechanism.

Authors:  Xiao-Le Xu; Hui Ji; Shu-Yi Gu; Qin Shao; Qiu-Ju Huang; Yan-Ping Cheng
Journal:  Phytother Res       Date:  2008-03       Impact factor: 5.878

View more
  2 in total

1.  Pharmacokinetic and Metabolism Studies of 12-Riboside-Pseudoginsengenin DQ by UPLC-MS/MS and UPLC-QTOF-MSE.

Authors:  Zhenzhou Wang; Hongqiang Lin; Hailin Zhu; Na Yang; Baisong Zhou; Cuizhu Wang; Pingya Li; Jinping Liu
Journal:  Molecules       Date:  2018-09-29       Impact factor: 4.411

Review 2.  The extraordinary transformation of traditional Chinese medicine: processing with liquid excipients.

Authors:  Zhi Chen; Si-Yong Ye; Rong-Gang Zhu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.